OtherInflammation and Immunopharmacology
Induction of C-X-C chemokines, growth-related oncogene (GRO)α expression and ENA-78, by ML-1 (IL-17F) involves activation of Raf1-MEK-ERK1/2 pathway
Mio Kawaguchi, Fumio Kokubu, Satoshi Matsukura, Koushi Ieki, Miho Odaka, Shin Watanabe, Shintaro Suzuki, Mitsuru Adachi and Shau-Ku Huang
Journal of Pharmacology and Experimental Therapeutics October 13, 2003, DOI: https://doi.org/10.1124/jpet.103.056341
Mio Kawaguchi
Fumio Kokubu
Satoshi Matsukura
Koushi Ieki
Miho Odaka
Shin Watanabe
Shintaro Suzuki
Mitsuru Adachi
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherInflammation and Immunopharmacology
Induction of C-X-C chemokines, growth-related oncogene (GRO)α expression and ENA-78, by ML-1 (IL-17F) involves activation of Raf1-MEK-ERK1/2 pathway
Mio Kawaguchi, Fumio Kokubu, Satoshi Matsukura, Koushi Ieki, Miho Odaka, Shin Watanabe, Shintaro Suzuki, Mitsuru Adachi and Shau-Ku Huang
Journal of Pharmacology and Experimental Therapeutics October 13, 2003, DOI: https://doi.org/10.1124/jpet.103.056341
OtherInflammation and Immunopharmacology
Induction of C-X-C chemokines, growth-related oncogene (GRO)α expression and ENA-78, by ML-1 (IL-17F) involves activation of Raf1-MEK-ERK1/2 pathway
Mio Kawaguchi, Fumio Kokubu, Satoshi Matsukura, Koushi Ieki, Miho Odaka, Shin Watanabe, Shintaro Suzuki, Mitsuru Adachi and Shau-Ku Huang
Journal of Pharmacology and Experimental Therapeutics October 13, 2003, DOI: https://doi.org/10.1124/jpet.103.056341
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement